Phase I Clinical Investigation of 1,4-Dihydroxy-5,8-bis{{ {2-[(2-hydroxyethyl)amino]ethyl} amino}} -9,10-anthracenedione Dihydrochloride (NSC 301739), a New Anthracenedione
Daniel D. Von Hoff, Ester Pollard, John Kuhn, Edward Murray, Charles A. Coltman
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Phase I Clinical Investigation of 1,4-Dihydroxy-5,8-bis{{ {2-[(2-hydroxyethyl)amino]ethyl} amino}} -9,10-anthracenedione Dihydrochloride (NSC 301739), a New Anthracenedione'. Together they form a unique fingerprint.